申请人:BRITISH BIOTECH PHARMACEUTICALS LIMITED
公开号:EP0905126A1
公开(公告)日:1999-03-31
Matrix metalloproteinase inhibiting compounds of formula (I)
wherein
Xis a -CO2H or -CONHOH group;
R1is methyl, ethyl, allyl, thienylsulphanylmethyl, thienylsulphinylmethyl, or thienylsulphonylmethyl;
R2is iso-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, propylsulphanyl, cyclohexylpropyl, phenylpropyl, 4-chlorophenylpropyl, 4-methylphenylpropyl, 4-methoxyphenylpropyl, phenylbutyl, or propyloxymethyl;.
R3is a group -C(C1-C6 alkyl)2R11 wherein
R11 is -OH, -SH, -O(C1-C6)alkyl, -S(C1-C6)alkyl, -SO(C1-C6)alkyl, -SO2(C1-C6) alkyl, cyclohexylmethylsulphanyl, -OPh, -OCH2Ph, -SPh, -SOPh, -SO2Ph, -SCH2Ph, -SOCH2Ph, or -SO2CH2Ph in which any of the foregoing Ph (phenyl) groups may be substituted;
R4is (C1-6)alkyl, (C1-C4)perfluoroalkyl or a group D-(C1-C6)alkyl- wherein D represents hydroxy, (C1-C6)alkoxy, (C1-C6)alkylsulphanyl, acylamino, optionally substituted phenyl or heteroaryl;
R5is hydrogen;
or a salt, hydrate or solvate thereof.
式(I)的基质金属蛋白酶抑制化合物
其中
X 是 -CO2H 或 -CONHOH 基团;
R1 是甲基、乙基、烯丙基、噻吩基硫代甲基、噻吩基亚磺酰基甲基或噻吩基亚磺酰基甲基;
R2 是异丁基、正戊基、正己基、正庚基、正辛基、正壬基、正癸基、丙磺酰基、环己基丙基、苯基丙基、4-氯苯基丙基、4-甲基苯基丙基、4-甲氧基苯基丙基、苯基丁基或丙氧基甲基;或
R3 是基团-C(C1-C6 烷基)2R11,其中
R11是-OH、-SH、-O(C1-C6)烷基、-S(C1-C6)烷基、-SO(C1-C6)烷基、-SO2(C1-C6)烷基、环己基甲基硫酰基、-OPh、-OCH2Ph、-SPh、-SOPh、-SO2Ph、-SCH2Ph、-SO2CH2Ph或-SO2CH2Ph,其中上述任何Ph(苯基)基团均可被取代;
R4 是 (C1-6)烷基、(C1-C4)全氟烷基或基团 D-(C1-C6)烷基,其中 D 代表羟基、(C1-C6)烷氧基、(C1-C6)烷基硫烷基、酰氨基、任选取代的苯基或杂芳基;
R5 为氢;
或其盐、水合物或溶液。